Structure Therapeutics News

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(3.3%),Peter Kolchinsky(3.3%), etc.

Nov 15 06:51

Structure Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(6.9%)

Nov 14 23:31

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)

Nov 14 22:37

Structure Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14 11:32

Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity

Nov 14 05:17

Structure Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital Research Global Investors(6.2%)

Nov 13 01:58

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Nov 12 23:40

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(13.95%),Wellington Group Holdings LLP(13.95%), etc.

Nov 8 23:55

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hall Ashley

Sep 21 05:52

Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Hall Ashley

Sep 21 05:47

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Coll Crespo Blas

Sep 21 05:47

Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Coll Crespo Blas

Sep 21 05:42

Structure Therapeutics | 8-K: Current report

Sep 18 04:21

Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Russell Angus C.

Aug 29 04:38

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Russell Angus C.

Aug 29 04:38

Structure Therapeutics | 8-K: Current report

Aug 28 04:20

Structure Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 04:40

Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

Aug 9 04:21

Structure Therapeutics | 8-K: Current report

Jun 28 05:04

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WELCH DANIEL G

Jun 28 04:20